Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Pazopanib vs Placebo in Stage I NSCLC
NCT00775307Phase 3Completed
- Sponsor
- IFCT
- Start
- Nov 2008
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pazopanib in non-small cell lung cancer (NSCLC), sponsored by IFCT. Started Nov 2008; status: completed.
02
Drugs
pazopanib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00775307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00775307.